Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Gilbert

Showing results (91-100 of 215) with videos related to

Pageof 22
Sort By:
Infection and Immunity|June 3, 2009
Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosisH Martin Vordermeier, Bernardo Villarreal-Ramos, Paul J Cockle, et al.
Scientific Reports|May 25, 2021
Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in miceKatharine A Collins, Florian Brod, Rebecca Snaith, et al.
Plos One|May 10, 2013
Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccineTimothy J Powell, Yanchun Peng, Tamara K Berthoud, et al.
Vaccine|September 10, 2005
Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosisSarah C Gilbert, Vasee S Moorthy, Laura Andrews, et al.
Human Vaccines & Immunotherapeutics|June 5, 2013
Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccinesRosalind Rowland, Geraldine A O'Hara, Matthew Hamill, et al.
Vaccines|August 26, 2022
Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and CamelsNaif Khalaf Alharbi, Fahad Aljamaan, Haya A Aljami, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malariaSheila M Keating, Philip Bejon, Tamara Berthoud, et al.
Plos One|November 3, 2012
A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 yearsRichard D Antrobus, Patrick J Lillie, Tamara K Berthoud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2011
The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirusSimone C de Cassan, Emily K Forbes, Alexander D Douglas, et al.
Plos One|June 24, 2011
Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1Sumi Biswas, Matthew D J Dicks, Carole A Long, et al.
Pageof 22

Showing results (91-100 of 215) with videos related to

Sort By:
Pageof 22
Infection and Immunity|June 3, 2009
Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosisH Martin Vordermeier, Bernardo Villarreal-Ramos, Paul J Cockle, et al.
Scientific Reports|May 25, 2021
Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in miceKatharine A Collins, Florian Brod, Rebecca Snaith, et al.
Plos One|May 10, 2013
Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccineTimothy J Powell, Yanchun Peng, Tamara K Berthoud, et al.
Vaccine|September 10, 2005
Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosisSarah C Gilbert, Vasee S Moorthy, Laura Andrews, et al.
Human Vaccines & Immunotherapeutics|June 5, 2013
Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccinesRosalind Rowland, Geraldine A O'Hara, Matthew Hamill, et al.
Vaccines|August 26, 2022
Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and CamelsNaif Khalaf Alharbi, Fahad Aljamaan, Haya A Aljami, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malariaSheila M Keating, Philip Bejon, Tamara Berthoud, et al.
Plos One|November 3, 2012
A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 yearsRichard D Antrobus, Patrick J Lillie, Tamara K Berthoud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2011
The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirusSimone C de Cassan, Emily K Forbes, Alexander D Douglas, et al.
Plos One|June 24, 2011
Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1Sumi Biswas, Matthew D J Dicks, Carole A Long, et al.
Pageof 22